Today, Infinix officially kicks off the global #NightSafariWithNOTE60Series contest, inviting mobile photography enthusiasts ...

In this article, we will be taking a look at the 10 Best Biotech Stocks Under $10 to Buy. According to Eli Casdin, CEO of ...

This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...

Chronic inflammatory diseases have traditionally been investigated as distinct clinical entities. However, growing evidence indicates that many of these ...

In a college that is roughly 50 percent female, an excess of women in some majors (e.g., ~75 percent in biology and psychology in the class of 2026, based on a hand-count of departmental major rosters ...

Generated $27.2 million in total net revenues, $11.6 million in gross profit before fair value adjustments or 43% of revenues, $6.0 million in adjusted EBITDA1 ...

Analysts are intrigued by SPY001’s early efficacy and dosing convenience, noting that the drug could compete with therapies ...

Felicia Beswick's two English bulldogs, 6-year-old Jax and 5-year-old Tun, couldn't be more different. "If you look at 'bulldog' in the dictionary, it's Jax; he's just very, very stereotypical of the ...

Mesoblast offers asymmetric risk-reward with Ryoncil's rapid pediatric SR-aGvHD launch and multiple late-stage pipeline catalysts. Learn why MESO stock is a hold.

Detailed price information for Rapid Dose Therapeutics Corp. (DOSE-CN) from The Globe and Mail including charting and trades.

Abington Heights Clarks Summit Elementary School fourth grader Jaime Morales is being recognized for his hard work on “The ...

A little more than a decade ago, Nate Eller was an standout student at Twin Hills Middle School in Sebastopol. Today, he’s an ...